How many employees does Bio-Techne have this year?
Bio-Techne has 2,250 undefined employees this year.
Bio-Techne Employees 2024
Bio-Techne Employees
2,250
Ticker
TECH
ISIN
US09073M1045
WKN
A12ENG
In 2024, Bio-Techne employed 2,250 people, a 0% change from the 2,250 number of employees in the previous year.
Bio-Techne Aktienanalyse
What does Bio-Techne do?
Bio-Techne Corp is a global company specializing in the research and development of innovative products and solutions in the field of biosciences. The company was founded in 1976 in Minneapolis and was formerly known as Techne Corporation. Since then, it has grown into an internationally renowned company through its numerous acquisitions and mergers. The company is headquartered in Minneapolis, Minnesota, USA. The business philosophy of Bio-Techne Corp is to help bioscientific researchers and clinicians around the world perform their work more effectively, efficiently, and quickly. The company works closely with its customers to provide them with suitable products and services, thereby developing innovative solutions to the challenges in bioscience. Bio-Techne Corp has various business segments, including protein platforms, diagnostics, genetic analysis, clinical controls, cell culture products, and research reagents. Each business segment offers a variety of products and services to support researchers and clinicians in their work. A key business segment of Bio-Techne Corp is the protein platform, which offers a comprehensive range of proteins, antibodies, and corresponding detection reagents. The company is known for its high-quality proteins and antibodies, which contribute to improving the research of diseases such as cancer, diabetes, and neurological and immunological disorders. Another important business segment of Bio-Techne Corp is diagnostics. Here, the company offers a wide range of clinical diagnostic products, such as tests for analyzing urea, creatinine, and bone density. The company's products help clinicians make precise diagnoses and treat patients more effectively. The genetic analysis segment offers DNA sequencing, gene expression, and genome-wide analysis products and services. These tools enable researchers to better understand the functioning of the human body by exploring the underlying genetic changes. The clinical controls segment offers product and service offerings that improve the reliability and accuracy of diagnostic systems. The company works closely with medical facilities to provide diagnostic solutions that deliver fast and accurate results. The cell culture products segment offers a complete range of solutions for cell cultivation and growth. The offering ranges from basic nutrient media and additives to culture vessels and accessories. The company's products enable researchers to culture cells in a controlled environment and under precise conditions. The last segment of Bio-Techne Corp includes research reagents. Here, the company offers a wide range of reagents used for protein, antibody, and cell function analysis and research. The products meet the needs of researchers in modern bioscience. In summary, Bio-Techne Corp is a company specialized in developing innovative solutions in bioscience, advancing science and medicine. With its products and services offered in various sectors, the company successfully helps researchers and clinicians perform their work faster, more effectively, and cost-efficiently. Bio-Techne ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining Bio-Techne's Employee Base
Bio-Techne's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Bio-Techne's operational capacity and future potential.
Year-to-Year Comparison
Assessing Bio-Techne's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
Bio-Techne's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in Bio-Techne’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about Bio-Techne stock
How many employees did Bio-Techne have compared to the previous year?
Compared to the previous year, Bio-Techne had 0% more employees.
What impact did the number of employees have on the company Bio-Techne?
The number of employees has a direct impact on the efficiency and productivity of Bio-Techne. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of Bio-Techne?
The number of employees can also have an impact on investors of Bio-Techne, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of Bio-Techne affect the company?
An increase in equity of Bio-Techne can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in Bio-Techne's equity affect the company?
A reduction in equity of Bio-Techne can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of Bio-Techne?
Some factors that can influence the equity of Bio-Techne include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of Bio-Techne so important for investors?
The equity of Bio-Techne is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at Bio-Techne influence the company?
The number of employees at Bio-Techne can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at Bio-Techne evolved in recent years?
In recent years, the number of employees at Bio-Techne has changed by 0.
How many employees does Bio-Techne currently have?
Bio-Techne currently has 2,250 undefined employees.
Why is the number of employees important for investors of Bio-Techne?
The number of employees is important for investors of Bio-Techne as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can Bio-Techne take to change the number of employees?
To change the number of employees, Bio-Techne can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does Bio-Techne pay?
Over the past 12 months, Bio-Techne paid a dividend of 0.32 USD . This corresponds to a dividend yield of about 0.42 %. For the coming 12 months, Bio-Techne is expected to pay a dividend of 0.32 USD.
What is the dividend yield of Bio-Techne?
The current dividend yield of Bio-Techne is 0.42 %.
When does Bio-Techne pay dividends?
Bio-Techne pays a quarterly dividend. This is distributed in the months of March, June, September, December.
How secure is the dividend of Bio-Techne?
Bio-Techne paid dividends every year for the past 21 years.
What is the dividend of Bio-Techne?
For the upcoming 12 months, dividends amounting to 0.32 USD are expected. This corresponds to a dividend yield of 0.43 %.
In which sector is Bio-Techne located?
Bio-Techne is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bio-Techne kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bio-Techne from 11/22/2024 amounting to 0.08 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.
When did Bio-Techne pay the last dividend?
The last dividend was paid out on 11/22/2024.
What was the dividend of Bio-Techne in the year 2023?
In the year 2023, Bio-Techne distributed 0.56 USD as dividends.
In which currency does Bio-Techne pay out the dividend?
The dividends of Bio-Techne are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Bio-Techne
Our stock analysis for Bio-Techne Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio-Techne Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
